HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,105-1,116 of 4,505
Drug study icon
TerminatedNCT02140788

Effects of Metformin and Fish Oil on Treatment With Clozapine

Official study title

A Comparison Of The Effects Of Added Metformin (Versus No Added Metformin) On Psychopathology, Lipids, And Measures of Inflammation During The Initiation Or Re-Institution Of Treatment With Clozapine In Patients With Schizophrenia Or Schizoaffective Disorder

This study ended early.

Location not clearly listed
SchizophreniaMedication studyAges 18–60
Countries
Sponsor
Duke University
Drug study icon
CompletedNCT00212836

Asenapine Compared With Olanzapine for schizophrenia

What is this study about?

Researchers compared asenapine and olanzapine, tracking side effects to assess safety in people with schizophrenia.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT00145496

Asenapine Compared With Olanzapine for schizophrenia

What is this study about?

Researchers compared Asenapine and Olanzapine, tracking side effects to assess safety in people with schizophrenia.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT04624243

Elpipodect for schizophrenia

Official study title

A Phase 2B Randomized, Double-Blind, Placebo- and Active-Controlled Trial of the Efficacy and Safety of MK-8189 in Participants Experiencing an Acute Episode of Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Bentonville
SchizophreniaMedication studyAges 18–55
Countries
United States, Bulgaria, Croatia, + 9 others
Sponsor
Merck Sharp & Dohme LLC
Drug study icon
CompletedNCT00254202

Iloperidone Compared With Placebo and Active Control for schizophrenia

Official study title

A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Iloperidone in Schizophrenic Patients in Acute Exacerbation Followed by a Long-term Treatment Phase.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States, India
Sponsor
Vanda Pharmaceuticals
Drug study icon
CompletedNCT01267188

NBI-98854 for adults with tardive dyskinesia

What is this study about?

This study evaluated the safety and effectiveness of NBI-98854 for people with schizophrenia.

This study has finished and is no longer accepting participants.

In Toronto
SchizophreniaMedication studyAges 18–65
Countries
Canada
Sponsor
Neurocrine Biosciences (Biotech company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.